We've found
9,220
archived clinical trials in
HIV / AIDS
We've found
9,220
archived clinical trials in
HIV / AIDS
Empowerment Intervention for Young Women - Phase I
Updated: 2/27/2017
A Secondary Prevention Empowerment Intervention for Young Women Living With HIV
Status: Enrolling
Updated: 2/27/2017
Empowerment Intervention for Young Women - Phase I
Updated: 2/27/2017
A Secondary Prevention Empowerment Intervention for Young Women Living With HIV
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Factors Affecting PrEP Adherence
Updated: 2/27/2017
Structural and Partnership Factors Affecting Adherence to Pre-exposure Prophylaxis (PREP)Among Young Men Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Microbicides Acceptability Among Sexually Active Young Women
Updated: 2/27/2017
Microbicide-Use Adherence, Acceptability, and Attitudes Among Sexually Active Young Women Participating in a Phase I Microbicide Trial (MTN 004) "Tell Juliana"
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Self-Consent for PrEP Perspectives
Updated: 2/27/2017
Participation in a Biomedical HIV Prevention Clinical Trial: Perspectives of Younger and Older Young Men Who Have Sex With Men (YMSM) and Transgender Women Who Have Sex With Men
Status: Enrolling
Updated: 2/27/2017
Click here to add this to my saved trials
Immune Activation and Drug Absorption in HIV-Infected Patients
Updated: 2/28/2017
Immune Activation and Drug Absorption in HIV-Infected Patients
Status: Enrolling
Updated: 2/28/2017
Immune Activation and Drug Absorption in HIV-Infected Patients
Updated: 2/28/2017
Immune Activation and Drug Absorption in HIV-Infected Patients
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
Chronic Hepatitis Intervention Project for Drug Users
Updated: 2/28/2017
Chronic Hepatitis Intervention Project for Drug Users
Status: Enrolling
Updated: 2/28/2017
Chronic Hepatitis Intervention Project for Drug Users
Updated: 2/28/2017
Chronic Hepatitis Intervention Project for Drug Users
Status: Enrolling
Updated: 2/28/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
C2P - Phase III: MPowerment and Community Promise
Updated: 3/2/2017
Connect-To-Protect® Phase III: Local Evaluation of Community Promise Connect-To-Protect® Phase III: Local Evaluation of Mpowerment
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Preventative Misconception Intervention
Updated: 3/2/2017
Evaluation of an Intervention to Reduce Preventive Misconception in HIV Vaccine Clinical Trials
Status: Enrolling
Updated: 3/2/2017
Click here to add this to my saved trials
Engaging HIV Patients in Primary Care by Promoting Acceptance
Updated: 3/8/2017
Engaging HIV Patients in Primary Care by Promoting Acceptance
Status: Enrolling
Updated: 3/8/2017
Engaging HIV Patients in Primary Care by Promoting Acceptance
Updated: 3/8/2017
Engaging HIV Patients in Primary Care by Promoting Acceptance
Status: Enrolling
Updated: 3/8/2017
Click here to add this to my saved trials
Effect of Cenicriviroc on HIV Neurocognitive Impairment
Updated: 3/14/2017
Randomized, Placebo-Controlled, Double-Blind, Pilot Study of CCR5/CCR2 Inhibitor Cenicriviroc (CVC) for HIV Associated Neurocognitive Disorder (HAND)
Status: Enrolling
Updated: 3/14/2017
Effect of Cenicriviroc on HIV Neurocognitive Impairment
Updated: 3/14/2017
Randomized, Placebo-Controlled, Double-Blind, Pilot Study of CCR5/CCR2 Inhibitor Cenicriviroc (CVC) for HIV Associated Neurocognitive Disorder (HAND)
Status: Enrolling
Updated: 3/14/2017
Click here to add this to my saved trials
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project
Updated: 3/21/2017
Minority AIDS Initiative Retention and Re-Engagement Project: Peer Re-Engagement Project
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).
Updated: 3/27/2017
A Phase I, Open Label, Randomized, Two Cohort, Two Period, Oneway Study to Evaluate the Effect of Boceprevir and Telaprevir onDolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697)
Status: Enrolling
Updated: 3/27/2017
A Study to Evaluate the Effect of Boceprevir and Telaprevir on Dolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697).
Updated: 3/27/2017
A Phase I, Open Label, Randomized, Two Cohort, Two Period, Oneway Study to Evaluate the Effect of Boceprevir and Telaprevir onDolutegravir Pharmacokinetics in Healthy Adult Subjects (ING115697)
Status: Enrolling
Updated: 3/27/2017
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Click here to add this to my saved trials
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Updated: 3/30/2017
A Phase I Open-Label Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Subtype C gp140 Vaccine With MF59 Adjuvant in Healthy, HIV-1 Uninfected Adult Participants Previously Primed or Unprimed With HIV-1 Subtype B Envelope Subunit Vaccines With MF59
Status: Enrolling
Updated: 3/30/2017
Click here to add this to my saved trials